About
Protara Therapeutics Inc (NASDAQ:TARA) — investor relations, events, news, and company updates on 6ix.
Latest News
Mar 10 2026
Protara Therapeutics Announces Fourth Quarter and Full Year 2025 Financial Results and Provides a Business Update
Feb 23 2026
TARA-002 Demonstrates 68% Complete Response Rate at Six Months in BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
Feb 2 2026
Protara Therapeutics, Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Jan 22 2026
Protara Therapeutics to Present Updated Interim Data from Phase 2 ADVANCED-2 Trial of TARA-002 in BCG-Unresponsive NMIBC Patients at the ASCO Genitourinary Cancers Symposium
Jan 12 2026
Protara Therapeutics Highlights Recent Updates and Anticipated 2026 Milestones
Recent Videos

Biotech is coming back around I JPM Healthcare Conference 2026
Mar 27, 2026

Cómo invertir en Protara Therapeutics Inc (TARA) paso a paso
Mar 11, 2026

How to Invest in Protara Therapeutics Inc (TARA) Step by Step
Mar 02, 2026

Protara Therapeutics: My $75M Stock Sale Insight
Dec 12, 2025
Google Übersetzer